PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)
Conditions:   Polycystic Kidney Disease, Adult;   Polycystic Kidney, Autosomal Dominant Interventions:   Drug: Aminohippurate Sodium Inj 20%;   Drug: Iohexol Inj 300 milligrams per milliliter (MG/ML);   Radiation: PET/CT Scan Sponsor:   University of Colorado Denver School of Medicine Barbara Davis Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials

A Study of LY3556050 in Healthy Participants
Condition:   Healthy Interventions:   Drug: LY3556050;   Drug: Placebo;   Drug: Iohexol;   Drug: Metformin Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2019 Category: Research Source Type: clinical trials

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Condition:   Heart Failure Interventions:   Drug: LCZ 696;   Drug: Icatibant;   Drug: placebo;   Drug: Para-aminohippurate;   Drug: Iohexol Sponsor:   Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
Conditions:   Diabetic Kidney Disease;   Type 1 Diabetes;   Diabetes;   Diabetes Mellitus;   Diabetes Complications;   Diabetic Nephropathies;   Type1diabetes;   Diabetes, Autoimmune;   Autoimmune Diabetes;   Juvenile Diabetes;   Type 1 Diabetes Mellitus Interventions:   Drug: Aminohippurate Sodium Inj 20%;   Drug: Iohexol Inj 300 milligrams/milliliter (mg/ml);   Radiation: PET/CT Scan Sponsors:   University of Colorado Denver School of Medicine Barbara Da...
Source: ClinicalTrials.gov - August 30, 2019 Category: Research Source Type: clinical trials